[P21] Poster Session 21　Palliative Care/Symptom Management 1

[P21-11] Effect of Olanzapine（2.5mg vs. 5mg） as prevention of highly emetogenic chemotherapy-induced nausea and vomiting

^○Yasuko Takeda¹, Yuki Takeyasu², Tatsuya Yoshida², Takamichi Arima¹, Daisuke Watabe¹, Mitsunobu Ishikawa¹, Toru Akagi¹, Hironobu Hashimoto¹, Ken Masuda², Yuji Matsumoto², Yuki Shinno², Yusuke Okuma², Yasushi Goto², Hidehito Horinouchi², Tetsuya Furukawa¹, Noboru Yamamoto², Yuichiro Ohe² (1.Department of Pharmacy, National Cancer Center Hospital, 2.Department of Thoracic Oncology, National Cancer Center Hospital)